The company has begun a rolling data submission from its vaccine candidate to UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for it to start its independent assessment of evidence as and when it becomes available. Moderna is among the frontrunners in the race to develop a vaccine for the new coronavirus, including Pfizer Inc, Johnson & Johnson and Astrazeneca – all in their late-stage trials, interim data from which are expected in the coming weeks. …read more
Source:: Yahoo Finance
